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intervals. The Z test was used to compare the AUCs of different scores. Calibration was assessed using the Pearson correlation coefficient and Hosmer-Lemeshow test. The α level of significance was determined as P<0.05, 2-sided. All analyses were performed with SAS 9.3 software.
Results
From May 2007 to April 2012, 1128 patients were entered into the TIMS-China registry. The baseline characteristics of all the patients are summarized in Table I in the online-only Data Supplement. The increased THRIVE score was associated with a higher risk of developing SICH, poor functional outcome, or death after thrombolysis (Table; Figure I in the online-only Data Supplement). Incidences of these poor outcomes in patients with 0 to 2, 3 to 5, and 6 to 9 points of the THRIVE score are listed in Table II in the online-only Data Supplement.
The AUC of the receiver operating characteristic curve of the THRIVE score was significantly greater than or similar to that of other scores (Table; Figure) . For predicting postthrombolytic SICH, the AUC of the THRIVE score was 0.69, compared with 0.61 of the SEDAN (P=0.01), 0.50 of the SPAN-100 (P<0.001), and 0.69 for NIHSS/age model (P=0.74), respectively. For poor outcome prediction, the AUC of the THRIVE score was 0.71, compared with 0. 
Discussion
Our study showed that the THRIVE score performed well in predicting the risks of SICH, poor functional outcomes, and death in Chinese patients with AIS after thrombolysis. This score was superior or similar to other prediction models when AUCs of the receiver operating characteristic curves were compared.
The THRIVE score can be easily calculated as soon as the patient's medical history is available and physical examination is completed. It is a better scoring model than Hemorrhage After Thrombolysis score and SPAN-100 for predicting postthrombolysis SICH. 5 Our study demonstrated that the THRIVE score was also superior to the SEDAN score, which required serum glucose levels. 2 The THRIVE score was reported to be inferior to the DRAGON score and NIHSS/age in predicting 
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poor outcome. 4 However, we found that the THRIVE score was better than the DRAGON score in predicting mortality.
Furthermore, our study showed that the THRIVE score was better in predicting mortality than developing SICH at 3 months. The possible explanation is that the patients' profiles were rather complete in predicting poor outcomes and death, whereas some important risk factors were absent in predicting SICH (pretreatment blood pressure, usage of antiplatelets, and statins). 1 Our study has several limitations. First, most of the participating hospitals in TIMS-China were urban hospitals. Second, changes in medical services during the 5-year study period might have influenced the study results. Third, the AUC of the THRIVE score in our study did not reach the threshold of 0.8, which was required for using on individuals. A previous study reported that the predictive scores were inaccurate when selecting patients with AIS for intravenous recombinant tissue-type plasminogen activator therapy in routine clinical practices because of its modest discriminatory power of scores. 4 However, the THRIVE score is a more accurate model than most other scoring systems in predicting clinical outcome in patients with AIS after intravenous thrombolysis. Table I Patients with THRIVE score of 8 was merged into score of 7 for small sample size (n=8). There is no patient in our study with THRIVE score of 9.
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